Main navigation
Search Results
-
-
Project BW2Pro - 29/08/2022 Biowaste to Products: biorefinery transforms biowaste into new products
In 2020, Germany’s population collected over 5 million tonnes of biowaste. Most of this was composted, and some was fermented into biogas. Scientists in Baden-Württemberg think there's room for more. Within the project ‘Biowaste to Products’ (BW2Pro) they want to transform biowaste into new products in a biorefinery. The idea is to produce biodegradable plant pots, mulch material, fertilisers, enzymes and biobased plastics in addition to…
https://www.biooekonomie-bw.de/en/articles/news/biowaste-products-biorefinery-transforms-biowaste-new-products -
Press release - 23/03/2021 AFYREN and Südzucker reach long term deal to supply factory producing biobased organic acids
AFYREN secures procurement of sugar beet co-products, major feedstock for industrial- scale production of its sustainable chemicals.
https://www.biooekonomie-bw.de/en/articles/pm/afyren-and-sudzucker-reach-long-term-deal-supply-factory-producing-biobased-organic-acids -
Press release - 30/09/2021 Essity begins tissue production from alternative fibers
Hygiene and health company Essity is today presenting a breakthrough in sustainable tissue production and is beginning production based on pulp from wheat straw. The plant in Mannheim, Germany, is the first of its kind in Europe, and the first on a large-scale tissue production in the world.
https://www.biooekonomie-bw.de/en/articles/pm/essity-begins-tissue-production-alternative-fibers -
Press release - 06/06/2024 Festo Expands its Portfolio with Multilayer Manifolds
Festo is expanding its portfolio to include multilayer manifolds made of plastic (bonded manifolds) in order to be able to offer manufacturers of medical and laboratory equipment solutions from a single source. To this end, Festo is taking over the production systems and processes for manufacturing these complex plastic manifolds from Carville, a leading company in this field.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/festo-expands-its-portfolio-multilayer-manifolds -
Dossier - 16/06/2014 Biotechnology as a tool for the production of food
Biotechnology opens up numerous opportunities for the food industry. The targeted use of biotechnological methods can help reduce the quantity and number of unhealthy ingredients in foods as well as degrade allergenic substances. Genomic research and targeted breeding also greatly facilitate progress in agriculture. Food biotechnology therefore contributes significantly to saving resources, optimising harvest yields and producing better foods.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/biotechnology-as-a-tool-for-the-production-of-food -
KyooBe Tech GmbH - 08/10/2020 Next generation vaccine production
For decades, conventional inactivated vaccines have been produced by killing pathogens with toxic chemicals. However, this process often changes the surface structure of the pathogens to such an extent that the immune system is only able to induce a weak response. KyooBe Tech GmbH is offering a method that uses low-energy electrons to inactivate pathogens. Vaccines produced this way are much higher quality, making them safer and more effective.
https://www.gesundheitsindustrie-bw.de/en/article/news/next-generation-vaccine-production -
Dossier - 16/06/2014 Biotechnology as a tool for the production of food
Biotechnology opens up numerous opportunities for the food industry. The targeted use of biotechnological methods can help reduce the quantity and number of unhealthy ingredients in foods as well as degrade allergenic substances. Genomic research and targeted breeding also greatly facilitate progress in agriculture. Food biotechnology therefore contributes significantly to saving resources, optimising harvest yields and producing better foods.
https://www.biooekonomie-bw.de/en/articles/dossiers/biotechnology-as-a-tool-for-the-production-of-food -
Alpha-Protein GmbH - 27/07/2021 Insect farming for sustainability
Mealworms instead of fish meal and soybean meal - this is what the sustainable future of feed production looks like as Alpha-Protein GmbH see it. The company has built a highly efficient automated production plant in which residual materials from local food production are used to breed mealworms.
https://www.biooekonomie-bw.de/en/articles/news/insect-farming-sustainability -
Sustainable medical technology - 10/10/2024 Rethinking plastics in medical technology
Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.
https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology -
Press release - 30/03/2021 Celonic and CureVac announce agreement to manufacture over 100 million doses of CureVac's Covid-19 vaccine candidate, CVnCoV
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on mRNA and Celonic Group, a premium biopharmaceutical Contract Development and Manufacturing Organization specializing in the development and production of Advanced Therapy Medicinal Products and mammalian cell line-expressed bio-therapeutics, announced their partnership for the production of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/celonic-and-curevac-announce-agreement-manufacture-over-100-million-doses-curevacs-covid-19-vaccine-candidate-cvncov -
Article - 27/05/2019 Providing Growledge - resources and products for the bioeconomy
Miscanthus and hemp are biomass plants that can be used as raw materials for a wide range of products and can be grown on land areas that are currently underutilised. A European consortium led by the University of Hohenheim in Baden-Württemberg has started a five-year project to demonstrate the economic potential of these plants.
https://www.biooekonomie-bw.de/en/articles/news/providing-growledge-resources-and-products-for-the-bioeconomy -
Press release - 15/11/2023 Nanoparticles for optimized cancer therapy
Pancreatic cancer is one of the deadliest types of cancers in humans. Chemotherapies attack not only the tumor cells but also healthy cells throughout the body. Innovative nanoparticles could be a new approach to treat cancer more precisely. The approach was developed by a research team from the Max Planck Institute (MPI) for Multidisciplinary Sciences, the University Medical Center Göttingen (UMG), and the Karlsruhe Institute of Technology.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanopartikel-fuer-optimierte-krebstherapie -
Press release - 03/07/2024 CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced a significant strategic restructuring to focus its resources on high-value mRNA projects in oncology and other select areas of substantial unmet medical need.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-initiates-strategic-restructuring-align-resources-focus-high-value-mrna-pipeline-opportunities -
Press release - 01/03/2022 CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer®
The RNA Printer® is CureVac’s integrated and automated manufacturing solution for RNA vaccines and therapeutics. CureVac RNA Printer GmbH to provide dedicated infrastructure to accelerate development and broaden application range of The RNA Printer®. Dr. Markus Bergmann appointed as General Manager for CureVac RNA Printer GmbH.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-gruendet-tochtergesellschaft-zur-weiterentwicklung-des-rna-printer -
Press release - 21/10/2022 Three years of ICM: Resource-efficient production – emission-free driving
Remaining mobile and producing without overtaxing the earth’s natural regenerative capacity: That’s the aim of the Innovation Campus “Mobility of the Future” (ICM) at the Karlsruhe Institute of Technology (KIT) and the University of Stuttgart. Here, in about 60 research projects and 40 research institutes, almost 300 scientists are working on electric motors without rare earths, novel manufacturing technologies, and self-learning software systems…
https://www.bio-pro.de/en/activities/biological-transformation/aktuelles/three-years-icm-resource-efficient-production-emission-free-driving -
Press release - 21/10/2022 Drei Jahre ICM: ressourcenschonend Produzieren – emissionsfrei Fahren
Mobil bleiben und produzieren, ohne die natürliche Regenerationsfähigkeit der Erde zu überfordern, das ist der Anspruch des InnovationsCampus Mobilität der Zukunft (ICM) am Karlsruher Institut für Technologie und der Universität Stuttgart. Fast 300 Forschende in gut 60 Forschungsprojekten und 40 -instituten arbeiten hier an Elektromotoren ohne Seltene Erden, neuartigen Fertigungstechnologien und selbstlernenden Software-Systemen für Fahrzeuge.
https://www.bio-pro.de/en/activities/biological-transformation/aktuelles/drei-jahre-icm-ressourcenschonend-produzieren-emissionsfrei-fahren -
Press release - 06/10/2022 New Electrolysis Processes for Sustainable Chemical Production
Basic chemicals, which are needed as raw materials for a wide range of products such as medicines and detergents, can currently only be produced with an enormously high input of energy and raw materials. In many cases, fossil fuels and raw materials are still used. The extraction of chemical substances alone requires high temperatures, expensive catalysts made of precious metals and, in some cases, environmentally harmful starting materials.
https://www.bio-pro.de/en/activities/biological-transformation/aktuelles/neue-elektrolyseverfahren-fuer-eine-nachhaltige-chemische-produktion -
Polysecure GmbH - 16/01/2020 Recycling of the future – marked plastic as a circular product
Plastics are harmful to the climate and human health both during manufacture and combustion and they also clutter our planet with garbage. Recycling is therefore a key issue, but it is not efficient. Polysecure has developed a process for permanently marking individual plastics that enables them to be separated efficiently and returned to a circular economy. This would counteract the vast amount of (micro) plastics and reduce CO₂ emissions.
https://www.biooekonomie-bw.de/en/articles/recycling-of-the-future-marked-plastic-as-a-circular-product -
Press release - 02/08/2021 CO2 as a raw material for plastics and other products
Carbon dioxide is one of the main drivers of climate change – which means that we need to reduce CO2 emissions in the future. Fraunhofer researchers are highlighting a possible way to lower these emissions: They use the greenhouse gas as a raw material, for instance to produce plastics. To do this, they first produce methanol and formic acid from CO2, which they convert via microorganisms into building blocks for polymers and the like.
https://www.biooekonomie-bw.de/en/articles/pm/co2-raw-material-plastics-and-other-products -
Press release - 06/10/2022 New Electrolysis Processes for Sustainable Chemical Production
Basic chemicals, which are needed as raw materials for a wide range of products such as medicines and detergents, can currently only be produced with an enormously high input of energy and raw materials. In many cases, fossil fuels and raw materials are still used. The extraction of chemical substances alone requires high temperatures, expensive catalysts made of precious metals and, in some cases, environmentally harmful starting materials.
https://www.biooekonomie-bw.de/en/articles/pm/neue-elektrolyseverfahren-fuer-eine-nachhaltige-chemische-produktion -
Project FuTuReS - 12/12/2022 Microalgae - high-quality products for domestic agriculture?
Algae are aquatic organisms that flourish in a huge variety of species. But that's not all: they are also small green mini-factories that can produce all kinds of valuable materials. All they need is water, light, CO2 and a few nutrients that can be recycled from biogas or sewage treatment plants. Researchers have now determined the optimal framework conditions and practicability of process methods for agricultural algae cultivation.
https://www.biooekonomie-bw.de/en/articles/news/microalgae-high-quality-products-domestic-agriculture -
Diatoms as a biorefinery - 05/05/2023 Microalgae: sustainable chemical production in a mini factory
Renewable raw materials that can be used as alternatives to fossil resources already exist. However, to turn them into everyday products, plant oils and other renewable raw materials not only have to be extracted, but often have to undergo complex chemical processing. Researchers at the University of Konstanz have now converted microalgae cells into tiny refineries to produce and upgrade raw materials, creating a supply of sustainable chemicals.
https://www.biooekonomie-bw.de/en/articles/news/microalgae-sustainable-chemical-production-mini-factory -
Dossier - 18/11/2013 Innovative textiles made possible by biotechnology
Biotechnology plays a part in many high-tech fabrics that have become an integral part of our everyday life. Whether it is products for the treatment of wounds, fabrics for marquees or for clothing, many materials have been developed or are produced using biotechnological techniques and processes. Many products marketed as “micro” or “nano” are inspired by nature.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/innovative-textiles-made-possible-by-biotechnology -
Dossier - 18/11/2013 Innovative textiles made possible by biotechnology
Biotechnology plays a part in many high-tech fabrics that have become an integral part of our everyday life. Whether it is products for the treatment of wounds, fabrics for marquees or for clothing, many materials have been developed or are produced using biotechnological techniques and processes. Many products marketed as “micro” or “nano” are inspired by nature.
https://www.biooekonomie-bw.de/en/articles/dossiers/innovative-textiles-made-possible-by-biotechnology -
Zero Bullshit Company - 31/05/2021 From being thrown away to becoming a recycled product - Stuttgart start-up produces healthy snacks
Throwing away food? The Stuttgart-based start-up Zero Bullshit Company is declaring war on food wastage by making nutrient-rich products largely from food industry leftovers. The three food technologists who created this transparent brand are looking to develop more than just delicious and nutritious products.
https://www.biooekonomie-bw.de/en/articles/news/being-thrown-away-becoming-recycled-product-stuttgart-start-produces-healthy-snacks -
Press release - 10/02/2022 CureVac Doses First Participant in Phase 1 Study with Multivalent Influenza Vaccine Candidate Based on Second-Generation mRNA Backbone Developed in Collaboration with GSK
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that it has dosed the first participant in a Phase 1 study of its seasonal influenza second-generation mRNA vaccine candidate, CVSQIV, developed in collaboration with GSK.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-doses-first-participant-phase-1-study-multivalent-influenza-vaccine-candidate-based-second-generation-mrna-backbone-deve -
Waste recycling in the healthcare sector - 30/01/2024 Sustainability in medical technology: a particular challenge
Quality and safety of medical care are top priorities in the healthcare sector. However, this is often at the expense of climate protection, as not only are energy and raw material consumption very high, but so is the amount of waste generated due to the large number of disposable products. Sustainable product design and improved recycling strategies are therefore required to reduce waste and the CO2 footprint.
https://www.gesundheitsindustrie-bw.de/en/article/news/sustainability-medical-technology-particular-challenge -
Press release - 30/11/2022 New Business Directory: Renewable Carbon Companies (ReCaCo)
Find companies that already offer fossil carbon free products, made from biomass, CO2 and recycling
https://www.biooekonomie-bw.de/en/articles/pm/new-business-directory-renewable-carbon-companies-recaco -
Press release - 01/02/2021 Targeting a rapid market breakthrough for new vaccine production method
In a so-called inactivated or killed vaccine, the virus particles it contains are first rendered inactive by means of the toxic chemical formaldehyde. A better way of achieving this, however, is to irradiate the pathogens with low-energy electrons. Four Fraunhofer Institutes have now developed a new method of vaccine production based on this technique that is not only quicker but also guarantees a higher quality of product.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/targeting-rapid-market-breakthrough-new-vaccine-production-method -
Paper technology - 10/03/2021 PLAFCO – a sustainable plastic substitute made from paper
Plastic is indispensable: it is cheap and practical and found in many disposable products such as drinking straws, disposable tableware or even packaging like bonded beverage cartons or bags – and it has a disastrous effect on the environment. The start-up company Plafco Fibertech Oy has developed a sustainable plastic substitute made of paper that could replace many disposable plastic products in the future.
https://www.biooekonomie-bw.de/en/articles/news/plafco-sustainable-plastic-substitute-made-paper -
Dossier - 16/12/2021 Advanced therapy medicinal products: gene and cell therapies
Novel gene and cell therapies for treating incurable and hereditary diseases have raised high expectations. However, success has so far been limited to the long-established bone marrow transplants involving the administration of haematopoietic stem cells used to treat blood cancer. CAR T-cell therapies have recently emerged as a major new hope in cancer treatment.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/advanced-therapy-medicinal-products-gene-and-cell-therapies -
Article - 10/07/2019 More than just a nut – new products for the bioeconomy
Plants are often used for one particular purpose only. However, walnut trees have much more to offer than just delicious nuts. The AlpBioEco project is studying the potential of walnut trees for the bioeconomy and how the potential can be exploited commercially. The international team of researchers is also focusing on apples and herbs.
https://www.biooekonomie-bw.de/en/articles/news/mehr-als-eine-harte-nuss-neue-produkte-fur-die-biookonomie -
Dossier - 04/11/2013 Biotechnology driver of innovation in the pharmaceutical industry
The biotech industry is the innovative driver for a pharmaceutical industry that, due to the shift from blockbluster products to personalised medicine, now depends on new concepts. The production of new drugs using genetic engineering relies on knowledge gained from genomics, proteomics and systems biology and creates new treatment strategies that combine therapy and diagnostics (i.e. companion diagnostics) to provide a specific individualised…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/biotechnology-driver-of-innovation-in-the-pharmaceutical-industry -
Producing valuable new products from waste materials - 07/01/2020 A vision: insect biorefineries as components of a sustainable bioeconomy
Eco-friendly and responsibly manufactured products are more in demand than ever before. Specific research is being carried out into materials and applications for a wide variety of uses. The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is working with Hermetia Baruth GmbH on the vision of an insect biofactory that uses waste materials to produce a wide range of products such as biosurfactants, animal feed or foils.
https://www.biooekonomie-bw.de/en/articles/news/A-vision-insect-biorefineries-as-components-of-a-sustainable-bioeconomy -
Press release - 07/08/2023 Vegan trend in Europe: In Germany, milk substitutes from plants are most popular alternative
Germany has the most active market, Southern Europe wants more variety, and people in Poland find dairy substitutes too expensive, according to a recent study by the University of Hohenheim.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/vegan-trend-europe-germany-milk-substitutes-plants-are-most-popular-alternative -
Press release - 07/08/2023 Vegan trend in Europe: In Germany, milk substitutes from plants are most popular alternative
Germany has the most active market, Southern Europe wants more variety, and people in Poland find dairy substitutes too expensive, according to a recent study by the University of Hohenheim.
https://www.biooekonomie-bw.de/en/articles/pm/vegan-trend-europe-germany-milk-substitutes-plants-are-most-popular-alternative -
Press release - 06/04/2022 Giant grass miscanthus: Bioethanol source with negative CO2 balance
European collaborative project led by the University of Hohenheim shows: Combining bioethanol production with carbon storage can effectively reduce CO2.
https://www.biooekonomie-bw.de/en/articles/pm/giant-grass-miscanthus-bioethanol-source-negative-co2-balance -
Press release - 18/03/2022 Less fossil oil in CO2-reducing plastics
The "carbonauten minus CO2 factory 1" will start production of 4,000 t of CO2-reducing plastic granules annually at favorable prices in summer 2022.
https://www.biooekonomie-bw.de/en/articles/pm/weniger-erdoel-co2-senkenden-kunststoffen -
Press release - 23/02/2023 Protecting the climate during textile production: polyester fibers bind CO2
Start for an EU-wide collaborative project: Under the leadership of the French company Fairbrics SAS, 17 project partners from 7 European countries are coming together. The common goal is to produce end products from polyester in a closed cycle using industrial CO2 emissions and to bring them to market maturity. The DITF produce synthetic fibers from plastics of non-fossil origin.
https://www.biooekonomie-bw.de/en/articles/pm/protecting-climate-during-textile-production-polyester-fibers-bind-co2 -
Research association - 24/07/2024 SPI-MP: pioneer in personalised medical technology
Every person is unique – even when they are ill. This is why many approaches to personalised medicine have been under development. The Stuttgart Partnership Initiative - Mass Personalization (SPI-MP), which focuses on basic research into fabrication and biomaterial technologies for personalised biomedical systems, is at the heart of such research work. The projects range from artificial knee joint cartilage to state-of-the-art stroke diagnostics.
https://www.gesundheitsindustrie-bw.de/en/article/news/spi-mp-pioneer-personalised-medical-technology -
Outlook on the future of agriculture - 30/11/2020 Agriculture 4.0 - ultramodern and without harmful plant protection products
The demand for organic products is continuing to grow; at the same time nature is being preserved – so why not switch completely to organic farming? The answer is simple: because not everyone can afford it, and with current consumption patterns not everyone would get enough to eat. A cooperative project is researching an an agricultural system that falls between conventional and organic farming.
https://www.biooekonomie-bw.de/en/articles/news/Agriculture-4-0-ultramodern-and-without-harmful-plant-protection-products -
Dossier - 09/12/2013 Industrial biotechnology biological resources for industrial processes
Industrial or white biotechnology uses microorganisms and enzymes to produce goods for industry, including chemicals, plastics, food, agricultural and pharmaceutical products and energy carriers. Renewable raw materials and increasingly also waste from agriculture and forestry are used for the manufacture of industrial goods.
https://www.biooekonomie-bw.de/en/articles/dossiers/industrial-biotechnology-biological-resources-for-industrial-processes -
Press release - 04/03/2021 CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vaccine Candidate, CVnCoV
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Novartis AG announced today that they have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV. Preparations for the start of production, technology transfers and test runs are already underway.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-and-novartis-sign-initial-agreement-manufacturing-covid-19-vaccine-candidate-cvncov -
Press release - 23/04/2021 For which plastic products is biodegradation a viable endof- life option?
The BioSinn project found products and applications for which biodegradation at the end-of-life is a real option. 25 fact sheets answer technical and regulatory questions for each application. The market volume of these applications was also estimated: in Germany it is about 170,000 tonnes, in the European Union about 1 million tonnes per year!
https://www.biooekonomie-bw.de/en/articles/pm/bei-welchen-kunststoffprodukten-ist-der-biologische-abbau-eine-sinnvolle-end-life-option -
Press release - 07/06/2021 For which plastic products is biodegradation a viable end-of-life option?
The final report including comprehensive fact sheets of 25 applications is now available online in German and English.
https://www.biooekonomie-bw.de/en/articles/pm/which-plastic-products-biodegradation-viable-end-life-option -
Dossier - 15/04/2013 Bioactive plant foods: more than just filling
Food that offers additional nutritional benefits is becoming increasingly important for example food that is able to prevent or treat diseases. This kind of food is therefore interesting for consumers the food industry and the healthcare sector alike. Products based on plant raw materials are particularly in demand due to the variety of natural health-promoting ingredients.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/bioactive-plant-foods-more-than-just-filling -
Press release - 13/06/2023 AutoProNano – international cooperation for in vitro and in vivo diagnostics
The AutoProNano German/French collaborative project involves developing a process for the automated production of nanoparticles for in vitro and in vivo diagnostics. The project is being launched within the smart analytics cooperation network. This international initiative has been funded by the Central Innovation Programme for SMEs (ZIM) of the German Federal Ministry for Economic Affairs and Climate Action (BMWK) since May 2020.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/autopronano-international-cooperation-vitro-and-vivo-diagnostics